Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 8

1.

Physiological melatonin inhibition of human breast cancer cell growth in vitro: evidence for a glutathione-mediated pathway.

Blask DE, Wilson ST, Zalatan F.

Cancer Res. 1997 May 15;57(10):1909-14.

PMID:
9157984
[PubMed - indexed for MEDLINE]
Free Article
2.

Melatonin and mammary cancer: a short review.

Sánchez-Barceló EJ, Cos S, Fernández R, Mediavilla MD.

Endocr Relat Cancer. 2003 Jun;10(2):153-9. Review.

PMID:
12790777
[PubMed - indexed for MEDLINE]
Free Article
3.

Melatonin and mammary pathological growth.

Cos S, Sánchez-Barceló EJ.

Front Neuroendocrinol. 2000 Apr;21(2):133-70. Review.

PMID:
10764528
[PubMed - indexed for MEDLINE]
4.

Oncostatic effects of the pineal gland.

Kerenyi NA, Pandula E, Feuer GM.

Drug Metabol Drug Interact. 1990;8(3-4):313-9. Review.

PMID:
2099893
[PubMed - indexed for MEDLINE]
5.

Breast cancer: a model system for studying the neuroendocrine role of pineal melatonin in oncology.

Blask DE, Lemus-Wilson AM, Wilson ST.

Biochem Soc Trans. 1992 May;20(2):309-11. Review. No abstract available.

PMID:
1397617
[PubMed - indexed for MEDLINE]
6.

Breast cancer, blindness and melatonin.

Coleman MP, Reiter RJ.

Eur J Cancer. 1992;28(2-3):501-3. Review.

PMID:
1591073
[PubMed - indexed for MEDLINE]
7.

Molecular mechanisms of melatonin's inhibitory actions on breast cancers.

Proietti S, Cucina A, Reiter RJ, Bizzarri M.

Cell Mol Life Sci. 2013 Jun;70(12):2139-57. doi: 10.1007/s00018-012-1161-8. Epub 2012 Sep 25. Review.

PMID:
23007844
[PubMed - indexed for MEDLINE]
8.

Historical aspects of glutathione and cancer chemotherapy.

Mistry P, Harrap KR.

Pharmacol Ther. 1991;49(1-2):125-32. Review.

PMID:
1852785
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk